Sage Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 7, 2023--Sage Therapeutics, Inc. (Nasdaq: SAGE) today reported business highlights and financial results for the third quarter ended September 30, 2023.“It has been an exciting time at Sage as we prepare for the upcoming commercial launch of ZURZUVAE, ...

